Submitted: 12 Mar 2020
Accepted: 01 May 2020
ePublished: 06 May 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2020;9(4): e35.
doi: 10.34172/jrip.2020.35
  Abstract View: 528
  PDF Download: 230

Case Report

Acute interstitial nephritis with immunotherapy; a growing entity?

John David Chetwood 1 * ORCID logo, Lin Lin Myat 1 ORCID logo, Helen Lammi 1, Mani Panat 1 ORCID logo, James Hughes 1 ORCID logo

1 Department of General Medicine, Tamworth Hospital, Dean St, Tamworth, NSW, Australia
*Corresponding author: John David Chetwood, Email: johnchetwood@doctors.org.uk


We report a case of acute kidney injury (AKI) secondary to immune-mediated acute interstitial nephritis (AIN), with supporting diagnostic results and a successful response to treatment. This entity is gaining increasing recognition with the burgeoning use of immunotherapy agents in oncology. The timeline for the development of AIN from the initiation of immunotherapy varies, and may range in severity from asymptomatic to severe, organ-threatening and with life threatening consequences. Renal biopsy should be performed to confirm the diagnosis due to the potential impact of discontinuation of immunotherapy on cancer survival. Re-challenge with immunotherapy is reasonable once renal function recovers.
Keywords: Acute Interstitial Nephritis, Checkpoint Inhibitor, immunotherapy, Nivolumab

Implication for health policy/practice/research/medical education:

Immune-mediated acute interstitial nephritis is the most commonly reported etiology for acute kidney injury related to immune checkpoint inhibitors.

Please cite this paper as: Chetwood JD, Myat LL, Lammi H, Panat M, Hughes J. Acute interstitial nephritis with immunotherapy; a growing entity? J Renal Inj Prev. 2020; 9(4): e35. doi: 10.34172/jrip.2020.35.

First Name
Last Name
Email Address
Security code

Abstract View: 528

Your browser does not support the canvas element.

PDF Download: 230

Your browser does not support the canvas element.